BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34383597)

  • 1. National Study of Pain Medicine Access Among Māori and Non-Māori Patients With Lung Cancer in New Zealand.
    Gurney JK; Stanley J; Adler J; McLeod H; Atkinson J; Sarfati D
    JCO Glob Oncol; 2021 Aug; 7():1276-1285. PubMed ID: 34383597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: A Universal Health Care Context.
    Gurney J; Davies A; Stanley J; Cameron L; Costello S; Dawkins P; Henare K; Jackson CGCA; Lawrenson R; Whitehead J; Koea J
    JCO Glob Oncol; 2024 Feb; 10():e2300258. PubMed ID: 38301179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equity of timely access to liver and stomach cancer surgery for Indigenous patients in New Zealand: a national cohort study.
    Gurney J; Sarfati D; Stanley J; Kerrison C; Koea J
    BMJ Open; 2022 Apr; 12(4):e058749. PubMed ID: 35487720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of lung cancers and accuracy and completeness of registration in the New Zealand Cancer Registry.
    Lawrenson R; Lao C; Brown L; Wong J; Middleton K; Firth M; Aitken D
    N Z Med J; 2018 Jul; 131(1479):13-23. PubMed ID: 30048429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
    Huria T; Palmer S; Beckert L; Williman J; Pitama S
    Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis.
    Metcalfe S; Laking G; Arnold J
    N Z Med J; 2013 Oct; 126(1384):14-41. PubMed ID: 24162628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage at diagnosis for Māori cancer patients: disparities, similarities and data limitations.
    Gurney J; Stanley J; Jackson C; Sarfati D
    N Z Med J; 2020 Jan; 133(1508):43-64. PubMed ID: 31945042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic differences in the management of lung cancer in New Zealand.
    Stevens W; Stevens G; Kolbe J; Cox B
    J Thorac Oncol; 2008 Mar; 3(3):237-44. PubMed ID: 18317065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equity of travel to access surgery and radiation therapy for lung cancer in New Zealand.
    Gurney J; Davies A; Stanley J; Whitehead J; Costello S; Dawkins P; Henare K; Jackson CGCA; Lawrenson R; Scott N; Koea J
    Support Care Cancer; 2024 Feb; 32(3):171. PubMed ID: 38378932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of COVID-19 on lung cancer detection, diagnosis and treatment for Māori in Aotearoa New Zealand.
    Gurney JK; Dunn A; Liu M; Mako M; Millar E; Ruka M; Crengle S; Dawkins P; Jackson C; Laking G; Sarfati D
    N Z Med J; 2022 Jun; 135(1556):23-43. PubMed ID: 35728246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where Are We Dying? Ethnic Differences in Place of Death Among New Zealanders Dying of Cancer.
    Gurney JK; Stanley J; Koea J; Adler J; Atkinson J; Sarfati D
    JCO Glob Oncol; 2022 May; 8():e2200024. PubMed ID: 35623019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The most commonly diagnosed and most common causes of cancer death for Māori New Zealanders.
    Gurney JK; Robson B; Koea J; Scott N; Stanley J; Sarfati D
    N Z Med J; 2020 Sep; 133(1521):77-96. PubMed ID: 32994639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004.
    Firestone RT; Wong KC; Ellison-Loschmann L; Pearce N; Jeffreys M
    J Epidemiol Community Health; 2009 Oct; 63(10):814-9. PubMed ID: 19574244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethnicity and rurality on treatment delays in patients with colorectal cancer in Northland, New Zealand.
    Matthews C; Walker M; McLaughlin S; Milloy M; Harmston C
    ANZ J Surg; 2021 Mar; 91(3):375-378. PubMed ID: 32869410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes.
    Sarfati D; Gurney J; Stanley J; Koea J
    BMC Cancer; 2014 Nov; 14():821. PubMed ID: 25380581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal?
    Hill S; Sarfati D; Blakely T; Robson B; Purdie G; Dennett E; Cormack D; Dew K; Ayanian JZ; Kawachi I
    Cancer; 2010 Jul; 116(13):3205-14. PubMed ID: 20564634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic disparity of pancreatic cancer in New Zealand.
    Phillips AR; Lawes CM; Cooper GJ; Windsor JA
    Int J Gastrointest Cancer; 2002; 31(1-3):137-45. PubMed ID: 12622425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update.
    Metcalfe S; Beyene K; Urlich J; Jones R; Proffitt C; Harrison J; Andrews Ā
    N Z Med J; 2018 Nov; 131(1485):27-47. PubMed ID: 30408816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand.
    Gurney J; Whitehead J; Kerrison C; Stanley J; Sarfati D; Koea J
    PLoS One; 2022; 17(8):e0269593. PubMed ID: 35951652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It is through shared conversation, that I understand"-Māori older adults' experiences of medicines and related services in Aotearoa New Zealand.
    Hikaka J; Jones R; Hughes C; Martini N
    N Z Med J; 2020 Jun; 133(1516):33-46. PubMed ID: 32525860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.